THAO LE: Open Payments
NPI 1467741298 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 24 payments from 12 companies in 2025. Trend: 2023 $251 · 2024 $711 · 2025 $752
Food & beverage: $752
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $211 |
| ABBVIE INC. | 3 | $151 |
| Lilly USA, LLC | 2 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Novo Nordisk Inc | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $39 |
| Exact Sciences Corporation | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: BREZTRI, QULIPTA, MOUNJARO, JARDIANCE, AIRSUPRA, XIFAXAN, Cologuard Collection Kit, Auvelity.
Industry payments across CA — which companies pay providers there.
